Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis
Open Access
- 1 November 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 16 (11), 2338-2342
- https://doi.org/10.1093/humrep/16.11.2338
Abstract
BACKGROUND: We have recently shown that patients with prostato-vesiculo-epididymitis (PVE) have a greater reactive oxygen species (ROS) overproduction than patients with prostatitis or prostato-vesiculitis. Since this biochemical stress persists even after treatment with antimicrobials, it may relate to an imbalance between pro- and anti-oxidant factors at the epididymal level. METHODS: To evaluate the effects of antioxidant treatment of patients with PVE, whether in the presence or absence of pro-oxidant factors, abacterial PVE infertile patients with normal (1×106/ml, group B, n = 20) seminal white blood cell (WBC) concentrations received carnitines (L-carnitine 1 g and acetyl-carnitine 0.5 g twice/day) for 3 months followed by a wash-out period of 3 months. Semen parameters, ROS production and pregnancy outcome were evaluated before, during and following carnitine treatment. RESULTS: Carnitines increased sperm forward motility and viability in group A patients. This was associated with a significant reduction in ROS production which persisted during wash-out. Carnitines increased only the percentage of viable spermatozoa in group B patients. Within 3 months after the discontinuation of carnitines, the rate of spontaneous pregnancy in group A patients was significantly higher than that of group B patients, being 11.7% (4/34) compared with 0%. CONCLUSION: These results indicate that carnitines are only an effective treatment in patients with abacterial PVE and elevated ROS production when seminal WBC concentration is normal.Keywords
This publication has 20 references indexed in Scilit:
- Mechanisms and effects of male genital tract infection on sperm quality and fertilizing potential: the andrologist's viewpointHuman Reproduction Update, 1999
- EFFECTS OF TAMOXIFEN, MELATONIN, COENZYME Q10, ANDl-CARNITINE SUPPLEMENTATION ON BACTERIAL GROWTH IN THE PRESENCE OF MYCOTOXINSPharmacological Research, 1998
- Antioxidant treatment for male subfertility: a promise that remains unfulfilledHuman Reproduction, 1998
- Free radicals, antioxidants and human spermatozoa: clinical implications.Human Reproduction, 1998
- L- carnitine in idiopathic asthenozoospermia: a multicenter studyAndrologia, 1994
- Expression of tumor necrosis factor-alpha in mouse spermatogenic cells.Endocrinology, 1993
- Carnitine and its acyl esters as secondary antioxidants?American Heart Journal, 1992
- Prospective analysis of sperm-oocyte fusion and reactive oxygen species generation as criteria for the diagnosis of infertilityAmerican Journal of Obstetrics and Gynecology, 1991
- Generation of Reactive Oxygen Species, Lipid Peroxidation, and Human Sperm FunctionBiology of Reproduction, 1989
- CARNITINE IN THE MALE REPRODUCTIVE TRACT AND ITS RELATION TO THE METABOLISM OF THE EPIDIDYMIS AND SPERMATOZOAPublished by Elsevier BV ,1980